Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
CMIC Group
Tokyo, Japan
A
5001-10000 Employees
1992
Key takeaway
The company, CMIC Group, highlights its harmo Vaccine Care service, which focuses on reliable vaccination management. This initiative addresses the increasing number of vaccination errors by providing tailored solutions that enhance the scheduling and administration processes.
Reference
Product
harmo Vaccination Care - CMIC | Pharmaceutical Development Services (CRO, CDMO, CSO, Healthcare, Japan Entry)
harmo Vaccine Care: Your Reliable Partner in Vaccination ManagementThe number of vaccination mistakes is increasing year by year, driven by the complex scheduling and administration processes. At harmo, we understand the importance of accurate vaccination management. In response to concerns such as not knowing when and what vaccine to get, we have developed "harmo Vaccine
mAbProtein
Izumo, Japan
A
1-10 Employees
2018
Key takeaway
mAbProtein is focused on supporting patients, doctors, and researchers through its antibody production capabilities.
Reference
Product
PRODUCT | マブプロテイン｜抗体製造 mAbProtein
Minaris Regenerative Medicine
Tokyo, Japan
A
501-1000 Employees
-
Key takeaway
Minaris Regenerative Medicine is a prominent contract development and manufacturing organization specializing in the production of cell and gene therapy products. With over 20 years of experience and state-of-the-art facilities, the company ensures high-quality manufacturing and efficient QP batch certification for therapies distributed in the EU market.
Reference
Service
QP Batch Certification | Minaris Regenerative Medicine
For cell and gene therapy products manufactured outside the European Union, Minaris Regenerative Medicine offers batch release to the EU market by Qualified Persons (QP).
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Medical Data Vision Co.,Ltd.
Tokyo, Japan
A
51-100 Employees
2003
Key takeaway
The company, MDV, focuses on enhancing the quality of medical and healthcare in Japan through the effective use of real-world data, which may be relevant for veterinary vaccine manufacturers looking for data-driven insights in their field.
Reference
Core business
Medical Data Vision Co., Ltd.
MEDICAL & BIOLOGICAL LABORATORIES
Nagoya, Japan
A
251-500 Employees
1969
Key takeaway
The company specializes in clinical diagnostic reagents, including immunology and serology testing products for autoimmune diseases and cancer-related tests.
Reference
Core business
臨床検査薬 | 事業紹介 | 医学生物学研究所 MBL
ReproCELL
Yokohama, Japan
A
51-100 Employees
2003
Key takeaway
REPROCELL specializes in translational research, offering a range of products and services that support stem cell research and regenerative medicine therapies. Their expertise in pluripotent stem cells and ongoing clinical trials for neurodegenerative diseases highlight their commitment to advancing therapeutic developments.
Reference
Product
KKN-CLF-01 - Atelocollagen Membrane
Purchase Atelocollagen Membrane from REPROCELL (KKN-CLF-01). Request a quote for delivery to the USA or Europe today.
Molcure
Tokyo, Japan
A
11-50 Employees
2013
Key takeaway
The company specializes in biopharmaceutical data analysis and employs advanced AI technology to identify valuable antibodies and peptides, which can be crucial for developing veterinary vaccines. Their innovative methods, including directed evolution experiments and machine learning, enhance the efficiency of drug discovery processes.
Reference
Core business
Molcure Inc. | Accelerating drug discovery
A&T Corporation
Yokohama, Japan
A
251-500 Employees
1988
Key takeaway
The company, A&T, is involved in the manufacturing and sales of clinical testing reagents, which supports medical care and contributes to global health.
Reference
Product
免疫血清検査試薬 | A&T
株式会社エイアンドティーは臨床検査情報システム・検体検査自動化システム・検体検査装置・臨床検査試薬の製造・販売を行っています。
Morinaga Institute of Biological Science Inc.
Yokohama, Japan
A
51-100 Employees
1980
Key takeaway
The company, Morinaga Institute of Biological Science, Inc., specializes in advanced immunoassay technology and has developed various test kits, including those for food allergens and animal feed. Their expertise in scientific research and product development contributes to enhancing health and safety standards.
Reference
Product
Test kit for animal feed and MBM (meat and bone meal) | Morinaga Institute of Biological Science, Inc.
Food allergy kit of the United States Government registered Morinaga Institute of Biological Science
Hamamatsu Pharma Research
Hamamatsu, Japan
A
- Employees
2006
Key takeaway
The company, Hamamatsu Pharma Research, specializes in drug development support, which may include services relevant to veterinary vaccine manufacturers. Their focus on efficient pharmaceutical development could be beneficial for those in the veterinary vaccine sector.
Reference
Core business
株式会社浜松ファーマリサーチ｜医薬品開発の効率化を実現する創薬支援会社
Technologies which have been searched by others and may be interesting for you:
When exploring the Veterinary Vaccine Manufacturers industry in Japan, several key considerations arise. Regulatory compliance is paramount, as Japan has stringent guidelines established by the Ministry of Agriculture, Forestry and Fisheries (MAFF) and the Pharmaceuticals and Medical Devices Agency (PMDA). These regulations govern vaccine development, testing, and approval processes, ensuring safety and efficacy. The competitive landscape is characterized by both domestic companies and international players, leading to a dynamic market environment. Companies must also navigate challenges such as high research and development costs and the need for advanced technologies to produce innovative vaccines. Opportunities exist within the growing pet population and increasing awareness of animal health, which drive demand for effective vaccines. Additionally, Japan's commitment to animal welfare and food safety enhances the industry's relevance on a global scale. Environmental concerns, such as the sustainability of vaccine production methods and the impact of waste disposal, are critical factors that companies must address to align with global standards. Lastly, collaboration with research institutions and participation in international trade can provide valuable insights and access to new markets, further enhancing the potential for growth in this sector.
Some interesting numbers and facts about your company results for Veterinary Vaccine Manufacturers
| Country with most fitting companies | Japan |
| Amount of fitting manufacturers | 9 |
| Amount of suitable service providers | 5 |
| Average amount of employees | 251-500 |
| Oldest suiting company | 1969 |
| Youngest suiting company | 2018 |
Some interesting questions that has been asked about the results you have just received for Veterinary Vaccine Manufacturers
What are related technologies to Veterinary Vaccine Manufacturers?
Based on our calculations related technologies to Veterinary Vaccine Manufacturers are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Veterinary Vaccine Manufacturers?
The most represented industries which are working in Veterinary Vaccine Manufacturers are Other, Biotechnology, Pharmaceuticals, IT, Software and Services, Medical
How does ensun find these Veterinary Vaccine Manufacturers Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.